오리건의 암 (전체) 임상 시험
암 (전체) 관련 연구 43개가 오리건 내 여러 지역에서 참여자를 모집하고 있습니다.
오리건의 도시
공식 연구 텍스트(영어)
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
- Legacy Medical Group-Surgical Oncology at Good Samaritan, Portland
피험자 모집 중
70세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07629206A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Willamette Valley Cancer Institute and Research Center /ID# 267088, Eugene
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT05650632Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- 외 10개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06580314A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Asante Rogue Regional Medical Center, Medford
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07169851A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- USO - Oncology Associates of Oregon, Eugene
- Asante Rogue Regional Medical Center, Medford
- Providence Portland Medical Center, Portland
- 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Willamette Valley Cancer Institute, Eugene
- Providence Portland Medical Center, Portland
- Oregon Health and Science University OHSU, Portland
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT03435796Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Williamette Valley Cancer Institute and Research Center, Eugene
- Compass Oncology - West, Tigard
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07566156A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Oregon Health and Science University /ID# 272282, Portland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06953960Connect for Cancer Prevention Study (Connect)
- Kaiser Permanente Northwest, Portland
피험자 모집 중관찰 연구건강한 지원자 환영
30세 ~ 70세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT04609072Galleri® in the Medicare Population.
- OHSU CEDAR Clinical Trials Columbia, Astoria
- OHSU CEDAR Clinical Trials Exchange, Astoria
- OHSU CEDAR Clinical Trials Beaverton, Beaverton
- 외 8개
피험자 모집 중건강한 지원자 환영
50세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT05673018A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- OHSU Center for Health & Healing 1, Portland
- Oregon Health and Science University, Portland
- OSHU Center for Health and Healing 2, Portland
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06989437A Study of ASP3082 in Adults With Advanced Solid Tumors
- Oregon Health and Science University, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT05382559A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
- Oregon Health & Science University, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT07725796A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Northwest Cancer Specialists /ID# 275151, Portland
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT07023289FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT05919264CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Providence Neurological Specialties West, Portland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT03328078A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Oregon Health and Science University ( Site 3004), Portland
피험자 모집 중1/2상
1 Month – 17 Years · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT06941272A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Providence Portland Medical Center /ID# 277727, Portland
피험자 모집 중2상
18세 이상 · 여성 · 2026. 10. 1. 업데이트됨 · NCT07024784A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Oregon Health & Science University, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07192471A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07127874A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Portland
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06881992A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Willamette Valley Cancer Institute and Research Center /ID# 280617, Eugene
- Oregon Health and Science University /ID# 280071, Portland
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Providence Health & Services, Portland
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT02693535A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Providence Cancer Institute, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- Providence Portland Medical Center, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07075185IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
- Oregon Health and Science University, Portland
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06206941Project: Every Child for Younger Patients With Cancer
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
피험자 모집 중관찰 연구
25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Oregon Health and Science University, Portland
피험자 모집 중2상
1세 ~ 39세 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT05999994Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 517, Eugene
피험자 모집 중2상
18세 이상 · 여성 · 2026. 7. 16. 업데이트됨 · NCT06906341Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
- OHSU Knight Cancer Institute, Portland
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT05705492Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Oregon Health and Science University, Portland
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT07216443First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Providence Cancer Institute Franz Clinic, Portland
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT05768139Molecular Genetics Studies of Cancer Patients and Their Relatives
- Saint Charles Health System, Bend
피험자 모집 중관찰 연구건강한 지원자 환영
전 연령 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT04185935A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Portland
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 25. 업데이트됨 · NCT06431594Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA Portland Health Care System, Portland, OR, Portland
피험자 모집 중
18세 ~ 75세 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT05486572I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Oregon Health & Science Institute (OHSU), Portland
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT01042379GEMINI-NSCLC: NSCLC Biomarker Study
- Oregon Oncology Specialists, Salem
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 2. 5. 업데이트됨 · NCT05236114Beat Childhood Cancer Specimen Banking and Data Registry
- Randall Children's Hospital, Portland
피험자 모집 중관찰 연구건강한 지원자 환영
전 연령 · 모든 성별 · 2026. 2. 3. 업데이트됨 · NCT04715178Caris Biorepository Research Protocol
- Bend Memorial Clinic, Bend
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 1. 21. 업데이트됨 · NCT01499394SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.